Orthofix Medical Inc.

NASDAQ:OFIX

Medical - Devices

Healthcare
$6.61 +0.33%

+$0.03 today

Market cap
$269.42M
Beta
0.71
P/E (TTM)
-6.2
EPS (TTM)
-$1.48
52W Low $9.12High $16.99

Volume 0.40M

Average 0.38M

OFIX Gross Profit

Revenue minus cost of revenue: what remains to cover operating expenses after paying for what was sold.

Orthofix Medical Inc.NASDAQ: OFIX

Gross Profit · Q1 FY2026 · quarter ended Mar 2026

Gross profit growth accelerates

Q1 FY2026 gross profit of $139.55M rose 14.7% year over year, ahead of the +5.4% change in trailing-twelve-month gross profit. Sequentially, it fell 1.7% from the prior quarter. Over 3 fiscal years it compounded at +17.8% a year.

Context

  • Gross profit amounted to 67.1% of revenue in FY2025, down 1.2 pp from a year earlier.
  • Gross profit increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +14.7% holds above the trailing-twelve-month pace of +5.4%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$139.55M-1.7% QoQ
Last fiscal yearDec 2025
$551.71M+1.1% YoY
LTMMar 2026
$569.63M+5.4% YoY
Gross Profit past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+14.7%——
1 year+1.1%——
3-year CAGR+17.8%——
5-year CAGR——
10-year CAGR——

Gross Profit history

USD · from the income statement

Latest · FY2025
551.71M USD
Year-over-year change
+1.1%
4-year CAGR
+12.1%

Gross Profit vs competitors

How OFIX compares with its peers on the latest reported figures

  • OFIX's LTM Mar 2026 gross profit of $569.63M is the highest of the 11 companies compared; the peer median is $54.99M.
  • Its year-over-year change of +5.4% is the 5th highest of 11, against a peer median of +0.3%.
  • Gross profit amounts to 69.0% of revenue for OFIX, versus a peer median of 49.2%.
OFIX Competitors Peer median
Gross Profit for OFIX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
OFIXOrthofix Medical Inc.LTM Mar 2026$569.63M +5.4%+17.8%69.0%
AVNSAvanos Medical, Inc.LTM Mar 2026$347.6M -7.9%-4.0%48.6%
VREXVarex Imaging CorporationLTM Apr 2026$287.7M +3.0%+0.8%33.6%
ESPREsperion Therapeutics, Inc.LTM Mar 2026$271.85M +60.4%+78.1%65.0%
SIBNSI-BONE, Inc.LTM Mar 2026$164.13M +17.3%+20.8%79.6%
PACBPacific Biosciences of California, Inc.LTM Mar 2026$59.34M +140.9%+1.1%37.1%
BFLYButterfly Network, Inc.LTM Mar 2026$50.64M -2.5%+5.0%49.2%
LABStandard BioTools Inc.LTM Mar 2026$41.66M -37.4%+4.7%48.3%
DRIODarioHealth Corp.LTM Mar 2026$11.98M -35.5%+9.5%56.5%
MLTXMoonLake ImmunotherapeuticsLTM Mar 2026-$2.34M -7090.5%——
ABSIAbsci CorporationLTM Mar 2026-$24.18M +48.7%—1316.9%
Peer median (excluding OFIX) $54.99M+0.3%+4.9%49.2%

Competitors are the stored peer set for OFIX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue464.48M460.71M746.64M799.49M822.31M
Cost of Revenue114.91M123.54M260.37M253.61M270.61M
Gross Profit349.57M337.17M486.27M545.89M551.71M
Gross Margin75.3%73.2%65.1%68.3%67.1%
Research & Development49.62M49.07M80.23M73.64M57.11M
Selling, General & Admin290.67M308.78M530.4M532.53M456.39M
Operating Expenses357.88M350.44M625.38M630.5M620.18M
Depreciation & Amortization33.1M32.08M60.56M60.06M50.97M
EBITDA21.44M15.66M(79.49M)(34.18M)(22.35M)
EBITDA Margin4.6%3.4%-10.6%-4.3%-2.7%
Operating Income(8.32M)(13.27M)(139.11M)(84.62M)(68.47M)
Operating Margin-1.8%-2.9%-18.6%-10.6%-8.3%
Interest Income00000
Interest Expense1.84M1.29M8.63M29.63M17.49M
Other Income / Expenses(5.18M)(4.44M)(9.57M)(39.26M)(22.34M)
Income Before Tax(13.5M)(17.71M)(148.68M)(123.88M)(90.81M)
Pre-Tax Margin-2.9%-3.8%-19.9%-15.5%-11.0%
Income Tax Expense24.88M2.04M2.72M2.12M1.38M
Net Income(38.38M)(19.75M)(151.4M)(126M)(92.19M)
Net Margin-8.3%-4.3%-20.3%-15.8%-11.2%
EPS (Basic)(1.95)(0.98)(4.12)(3.30)(2.28)
EPS (Diluted)(1.95)(0.98)(4.12)(3.30)(2.28)
Weighted Avg Shares19.69M20.1M36.73M38.13M39.88M
Weighted Avg Shares (Diluted)19.69M20.1M36.73M38.13M39.88M

Orthofix Medical Inc.

NASDAQ:OFIX

Intrinsic Alpha fair value

Locked

Current Price

$6.61

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.